Medical Device Innovation Consortium is a 501(c)(3) organization, classified under Medical Research (NTEE H99). Contributions are tax-deductible.
1655 Fort Myer Dr Ste 250, Arlington, VA 22209-3120
Among the 3 scored medical research organizations in Arlington, Medical Device Innovation Consortium holds 0.9 months of operating reserves (peer median 12.6 months), runs a typical yearly deficit of 4.7% (peers: deficit of 1.2%), and has grown spending 40.6% a year (peers: grown spending 17.5% a year).
In fiscal year 2024 it reported $28,171,331 in revenue and $28,147,444 in expenses, with contributions making up 80.5% of revenue.
Break down barriers in the medical technology life cycle to accelerate innovation and adoption of safe, effective and high-quality medical technologies.
Largest programs · fiscal year 2024
National evaluation system for health technology coordinating center:the national evaluation system for health technology (nest) is an initiative of mdic which serves as a catalyst in establishing functional and efficient pathways for key stakeholders to generate lower-cost, nearer real-time real-world evidence (rwe) of sufficient quality for regulatory, coverage, patient, and clinical decision-ma… Read more
National evaluation system for health technology coordinating center:the national evaluation system for health technology (nest) is an initiative of mdic which serves as a catalyst in establishing functional and efficient pathways for key stakeholders to generate lower-cost, nearer real-time real-world evidence (rwe) of sufficient quality for regulatory, coverage, patient, and clinical decision-making. By solving the challenges that have slowed medical device innovation, delayed the detection of safety signals, and created inefficiencies, nestcc could improve patients' timely access to safe medical devices and their quality of life.
$15,109,411 spent · 65.9% of program spending
Science and technology:science and technology's focus involves developing tools and methods to enhance efficiency (in terms of time and resources), quality, design, manufacturing, and a predictable pathway in data collection and evidence development. The organization's clinical science program aims to improve diagnostic testing and product development by supporting manufacturers in obtaining credi… Read more
Science and technology:science and technology's focus involves developing tools and methods to enhance efficiency (in terms of time and resources), quality, design, manufacturing, and a predictable pathway in data collection and evidence development. The organization's clinical science program aims to improve diagnostic testing and product development by supporting manufacturers in obtaining credible clinical evidence patient preferences and facilitating first-in-world patient access to safe and effective new technologies of significant health importance.
$6,521,269 spent · 28.4% of program spending
Health economics and patient value:mdic's value-based healthcare projects are developed to improve the industry's ability to real world evidence and include patient perspectives in the development, pre-market approval, and post-market evaluation of medical devices and support a more predictable pathway in reimbursement decisions under federal healthcare programs.$744,488 spent · 3.2% of program spending
Development and membership$563,698 spent · 2.5% of program spending
Where each dollar went · fiscal year 2024
Of every dollar it spent, 81¢ went to programs, 19¢ to management and 0¢ to fundraising.
Programs $22,938,866
Management $5,208,578
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
82%
Meets
Compared with Arlington peers
Measure
This organization
Peer median
Operating reserves
0.9 mo
12.6 mo
Typical margin
−4.7%
−1.2%
Spending growth
+40.6% / yr
+17.5% / yr
Debt load
82.1%
29.0%
Peers: the 3 Arlington medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$28,171,331Fiscal year 2024
Expenses$28,147,444Fiscal year 2024
Total assets$11,814,781Fiscal year 2024
Total liabilities$9,698,496Fiscal year 2024
Fiscal year ending December2024
Revenue$28,171,331
Expenses$28,147,444
Net income$23,887
Net assets$2,116,285
Notable sources of revenue
Percent of total revenue
Contributions
$22,684,960
80.5%
Program services
$5,459,148
19.4%
Investment income
$27,223
0.1%
Other (net)
$0
0.0%
Assets / debt
Total assets
$11,814,781
Total liabilities
$9,698,496
Net assets
$2,116,285
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$14,899,712
Expenses$15,639,936
Net income−$740,224
Net assets$2,092,398
Notable sources of revenue
Percent of total revenue
Contributions
$9,899,161
66.4%
Program services
$4,974,275
33.4%
Investment income
$26,276
0.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$11,871,420
Total liabilities
$9,779,022
Net assets
$2,092,398
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$10,710,909
Expenses$14,247,437
Net income−$3,536,528
Net assets$2,832,622
Notable sources of revenue
Percent of total revenue
Contributions
$10,002,314
93.4%
Program services
$1,688,525
15.8%
Investment income
$12,404
0.1%
Other (net)
−$992,334
−9.3%
Assets / debt
Total assets
$11,514,040
Total liabilities
$8,681,418
Net assets
$2,832,622
Compensation
Officers and key employees
$3,006,669
Share of expenses
21.1%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?